Intra-Cellular Therapies to Host Second Quarter 2024 Financial Results Conference Call and Webcast
Intra-Cellular Therapies(ITCI) GlobeNewswire News Room·2024-07-24 20:00
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Wednesday, August 7, 2024, to provide a corporate update and discuss details of the Company's financial results for the quarter ended June 30, 2024. To attend the live conference c ...